SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Reliance Life Sciences gets license for gene therapy technology from IIT Kanpur

10 Mar 2023 Evaluate

Reliance Life Sciences, part of the Promoter Group of Reliance Industries, has received license for gene therapy technology that has the potential to treat many hereditary eye diseases from The Indian Institute of Technology Kanpur. The gene therapy technology from IIT Kanpur will be further developed as an indigenous product by Reliance Life Sciences. Gene therapy using viral vectors has recently emerged as a potent tool in the field of molecular medicine. This is the first time that a gene therapy related technology has been developed and transferred from an academic institution to a company in India.

Reliance Life Sciences is a research-driven organization developing business opportunities in bio-therapeutics (plasma proteins, biosimilars and novel proteins), pharmaceuticals (later-generation, oncology generics), clinical research services, regenerative medicine (stem cells therapies) and molecular medicine.

Reliance Industries is India’s largest private sector company. The company’s activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and 4G digital services.

Reliance Industries Share Price

1365.10 21.65 (1.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Reliance Industries 1365.10
Indian Oil Corp. 145.85
BPCL 312.05
HPCL 370.95
MRPL 183.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×